![]()
New Treatment for Acromegaly
Reply
![]() |
|
From:
![]() ![]() PTResearcher
|
| OU professor discovers and markets important new growth-hormone drug | | 2004-02-26 | | By Megan Miladinov | | Athens NEWS Campus Reporter | ![]() |
An Ohio University scientist with a national reputation gave a public talk Tuesday about his discovery of a growth-hormone inhibitor designed to help patients suffering from a disease characterized by large stature, fingers, hands, feet and skull bones. The drug may eventually be used to treat more-common ailments such as diabetes and cancer.
"When drugs are approved, it's time to celebrate," declared John Kopchick, a professor of molecular biology in the Ohio University College of Osteopathic Medicine. Kopchick spoke on "Football, Dirty Shorts, Mini-Mice and a New Drug" during a colloquium in the new classroom building.
During the talk, he explained the process by which he discovered pegvisomart (brand name Somavert), which is currently being marketed by drug megacorporation Pfizer in the United States and Europe. The FDA-approved drug is used to treat acromegaly.
| |
|
View other groups in this category.
![]()
![]() |
To stop getting this e-mail, or change how often it arrives, go to your E-mail Settings.
Need help? If you've forgotten your password, please go to Passport Member Services.
For other questions or feedback, go to our Contact Us page.
If you do not want to receive future e-mail from this MSN group, or if you received this message by mistake, please click the "Remove" link below. On the pre-addressed e-mail message that opens, simply click "Send". Your e-mail address will be deleted from this group's mailing list.
Remove my e-mail address from Pituitary Chat.
|
|
